Disease/Infection News

RSS

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

"A paper published in Nature on Monday sheds light on how a vaccine can turn the immune system against [HIV] and so offer protection from infection," Nature News reports, noting "[t]he results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week."

12 Sep 2012

Researchers identify novel genes that make some children cope with malaria

Researchers from Sainte-Justine University Hospital Center and University of Montreal have identified several novel genes that make some children more efficient than others in the way their immune system responds to malaria infection.

12 Sep 2012

Diet could avert toxic effects of quinine in patients with malaria

Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat.

12 Sep 2012

Researchers investigate whether altruism influences parental decisions to vaccinate children

As outbreaks of preventable diseases such as whooping cough and measles increase in the United States, researchers from the Regenstrief Institute and Indiana University School of Medicine are investigating whether altruism, known to influence adults' decisions to immunize themselves, influences parental decisions to vaccinate their children.

12 Sep 2012

AIDS activists in China protest for better care for those affected by 1990s blood-selling schemes

The Economist reports on a demonstration by about 300 people living with HIV and activists outside the headquarters of China's Henan provincial government in Zhengzhou on August 27.

12 Sep 2012

Novel method could help advance fight against persistent 'HIV latency'

Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection-by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

12 Sep 2012

Devex news analysis examines Democratic, Republican party platforms on foreign policy, including global health

A Devex news analysis examines the Democratic and Republican platform positions on foreign policy following the party conventions, writing, "Even as pocketbook concerns continue to overshadow foreign policy issues on the campaign trail, in both Charlotte and Tampa, top-billed speakers made the case for the U.S. foreign aid program."

12 Sep 2012

Religious groups play positive and critical roles in fighting AIDS epidemic

While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive -- and critical -- roles in fighting the epidemic, according to sociologists.

12 Sep 2012

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Santarus, Inc. today announced that its Phase III clinical study to evaluate the safety and efficacy of the investigational drug, rifamycin SV MMX, met the primary endpoint of reducing time to last unformed stool (TLUS) in patients with travelers' diarrhea.

12 Sep 2012

Durata Therapeutics completes dalbavancin Phase 3 trials on ABSSSI

Durata Therapeutics today announced results from its QT study of the company's lead product candidate, dalbavancin. Dalbavancin is currently under investigation in two ongoing, global, Phase 3 clinical trials for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

11 Sep 2012

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics against nosocomial infections.

11 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Although people often say they have "strep" throat, most sore throats actually are caused by a virus, not streptococcus bacteria, and shouldn't be treated with antibiotics, suggest guidelines published by the Infectious Diseases Society of America (IDSA). Antibiotics are ineffective against viruses.

11 Sep 2012

Methodist Hospital develops new technology to rapidly detect drug-resistant TB

Technology developed by scientists at The Methodist Hospital Research Institute could halve the time it takes to diagnose tuberculosis infection, and also tell doctors in a day or two whether the bacteria are drug resistant -- a process that currently takes weeks. Initial tests of the device were recently described in Scientific Reports, a Nature online journal.

11 Sep 2012

Democrats, Republicans can agree on U.S. accomplishments in global health, development

"With back-to-back Republican and Democratic National Conventions, it's natural to focus on our differences," but "I am heartened to see the bipartisan support that exists for U.S. leadership in the world -- particularly for our global development efforts," Dan Glickman, former secretary of agriculture and chair of the Board of the Center for U.S. Global Leadership, writes in a Politico opinion piece.

11 Sep 2012

Blog features interview with former UNAIDS Executive Director about lessons learned fighting AIDS

PSI's "Global Health Impact" blog features a video interview by the Center for Strategic & International Studies (CSIS) in which "former UNAIDS Executive Director Peter Piot discusses with CSIS Senior Vice President and Director of the Global Health Policy Center J. Stephen Morrison the lessons he has learned in his years fighting AIDS."

11 Sep 2012

Speakers at panel discussion explore policy implications of findings on HIV transmission among MSM

The Center for Strategic and International Studies (CSIS) on Thursday hosted a panel discussion focusing on the policy implications of findings published by the Lancet in a special series on HIV/AIDS and men who have sex with men (MSM), the Center for Global Health Policy's "Science Speaks" blog reports.

11 Sep 2012

Most Asian countries fail to include rotavirus vaccine in national immunization programs citing cost as barrier

"Most countries in Asia have yet to make the rotavirus vaccine part of their national immunization program (NIP), despite a World Health Organization (WHO) recommendation to do so," IRIN reports.

11 Sep 2012

CSL Biotherapies receives U.S. Government contract to supply pandemic vaccine antigens

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced it has been awarded a contract by the United States (U.S.) Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.

11 Sep 2012

AHRQ-funded project reduces rate of central line-associated bloodstream infections in ICUs by 40%

A unique nationwide patient safety project funded by the Agency for Healthcare Research and Quality (AHRQ) reduced the rate of central line-associated bloodstream infections (CLABSIs) in intensive care units by 40 percent, according to the agency's preliminary findings of the largest national effort to combat CLABSIs to date.

11 Sep 2012

Disease/Infection News

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

Researchers identify novel genes that make some children cope with malaria

Diet could avert toxic effects of quinine in patients with malaria

Researchers investigate whether altruism influences parental decisions to vaccinate children

AIDS activists in China protest for better care for those affected by 1990s blood-selling schemes

Novel method could help advance fight against persistent 'HIV latency'

Devex news analysis examines Democratic, Republican party platforms on foreign policy, including global health

Religious groups play positive and critical roles in fighting AIDS epidemic

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Durata Therapeutics completes dalbavancin Phase 3 trials on ABSSSI

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

First demonstration of newly developed dual humanized FRGTM KO system against malaria

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Methodist Hospital develops new technology to rapidly detect drug-resistant TB

Democrats, Republicans can agree on U.S. accomplishments in global health, development

Blog features interview with former UNAIDS Executive Director about lessons learned fighting AIDS

Speakers at panel discussion explore policy implications of findings on HIV transmission among MSM

Most Asian countries fail to include rotavirus vaccine in national immunization programs citing cost as barrier

CSL Biotherapies receives U.S. Government contract to supply pandemic vaccine antigens

AHRQ-funded project reduces rate of central line-associated bloodstream infections in ICUs by 40%

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News